US Bancorp
MIST icon

US Bancorp’s Milestone Pharmaceuticals MIST Stock Holding History

US Bancorp’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.29K Hold
3,200
– – ﹤0.01% 3702
2026
Q1 		$3.81K Hold
3,200
– – ﹤0.01% 3646
2025
Q4 		$6.46K Hold
3,200
– – ﹤0.01% 3457
2025
Q3 		$6.4K Hold
3,200
– – ﹤0.01% 3461
2025
Q2 		$6.21K Hold
3,200
– – ﹤0.01% 3571
2025
Q1 		$2.56K Buy
+3,200
New +$6.36K ﹤0.01% 3826

Other funds holding MIST

PCM
Pavaki Capital Management Pueblo, Colorado $287M AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return

US Bancorp's MIST Position: Q2 2026 in Review

US Bancorp held its Milestone Pharmaceuticals (MIST) position steady in Q2 2026 at 3,200 shares worth $4.29K. The position accounts for ﹤0.01% of the portfolio, ranked #3702.

US Bancorp first reported a position in MIST in Q1 2025 and has held it in 6 quarters since. The position peaked at $6.46K in Q4 2025. 78 funds tracked by Wall St. Rank hold MIST as of Q2 2026.

  • US Bancorp held 3,200 shares of Milestone Pharmaceuticals worth $4.29K as of Q2 2026.
  • US Bancorp left its Milestone Pharmaceuticals share count unchanged in Q2 2026.
  • Milestone Pharmaceuticals made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #3702 holding.
  • US Bancorp first reported a position in Milestone Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • US Bancorp's Milestone Pharmaceuticals position peaked at $6.46K in Q4 2025.
  • 78 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.